Matches in Wikidata for { <http://www.wikidata.org/entity/Q92465221> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q92465221 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92465221 description "scientific article published on 30 May 2019" @default.
- Q92465221 description "wetenschappelijk artikel" @default.
- Q92465221 description "наукова стаття, опублікована 30 травня 2019" @default.
- Q92465221 name "Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis" @default.
- Q92465221 name "Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis" @default.
- Q92465221 type Item @default.
- Q92465221 label "Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis" @default.
- Q92465221 label "Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis" @default.
- Q92465221 prefLabel "Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis" @default.
- Q92465221 prefLabel "Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis" @default.
- Q92465221 P1433 Q92465221-7FE0F983-8E31-4F44-AD72-E106BBE6C6CC @default.
- Q92465221 P1476 Q92465221-AB9F9563-9265-4817-B1AD-D71B248A94BD @default.
- Q92465221 P2093 Q92465221-03499080-5B2A-4D37-9558-48AD3B472568 @default.
- Q92465221 P2093 Q92465221-21804AF0-4CCB-47F8-B260-DBA07405E767 @default.
- Q92465221 P2093 Q92465221-328F69A9-BF4D-43CF-A158-5FDE61ACC341 @default.
- Q92465221 P2093 Q92465221-59843A69-CAB1-4351-9176-E0BF518F2A2F @default.
- Q92465221 P2093 Q92465221-A39CE6A5-7DB4-437F-B4B1-EDBD64A1ECF1 @default.
- Q92465221 P2093 Q92465221-B7AB8896-F0E4-4E87-B24F-D8FEA5C5A257 @default.
- Q92465221 P2093 Q92465221-E2948C20-8307-486B-93C9-0A9F8989D5A8 @default.
- Q92465221 P304 Q92465221-E008FCF7-39BC-4F45-8E6A-EB33FCCD8196 @default.
- Q92465221 P31 Q92465221-3366C694-24F4-4303-865B-0646676A92D5 @default.
- Q92465221 P356 Q92465221-D5124058-6F70-489D-B4F5-8F4A1E5BF6B6 @default.
- Q92465221 P478 Q92465221-21634AB4-CB95-412B-829F-D5B8DB6FB012 @default.
- Q92465221 P50 Q92465221-45C848EF-E491-42B4-B116-335EB1B4BD0E @default.
- Q92465221 P577 Q92465221-C35AEE67-5E54-4FAC-B010-07864BA4A458 @default.
- Q92465221 P698 Q92465221-86AAF724-D94F-46B8-98DA-61714DE4D331 @default.
- Q92465221 P921 Q92465221-0BDCA5D3-BC6E-475A-A2B5-6CC4677F756E @default.
- Q92465221 P921 Q92465221-8AB63327-1265-4D96-83CD-40323982CBA7 @default.
- Q92465221 P356 J.INTIMP.2019.05.042 @default.
- Q92465221 P698 31154289 @default.
- Q92465221 P1433 Q15751306 @default.
- Q92465221 P1476 "Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis" @default.
- Q92465221 P2093 "Fei Gao" @default.
- Q92465221 P2093 "Hongyue Diao" @default.
- Q92465221 P2093 "Lian Cui" @default.
- Q92465221 P2093 "Lingling Zhang" @default.
- Q92465221 P2093 "Qian Yu" @default.
- Q92465221 P2093 "Yu Gong" @default.
- Q92465221 P2093 "Yunlei Tong" @default.
- Q92465221 P304 "442-450" @default.
- Q92465221 P31 Q13442814 @default.
- Q92465221 P356 "10.1016/J.INTIMP.2019.05.042" @default.
- Q92465221 P478 "73" @default.
- Q92465221 P50 Q83396956 @default.
- Q92465221 P577 "2019-05-30T00:00:00Z" @default.
- Q92465221 P698 "31154289" @default.
- Q92465221 P921 Q10355321 @default.
- Q92465221 P921 Q422232 @default.